Vertical product differentiation and social health systems in a market for prescription drugs: Revised version of a talk given at the 2. World Congress on Health Economics in Zürich, Sept. 10 - 14, 1990

Anette Boom

No 250, Discussion Papers, Series I from University of Konstanz, Department of Economics

Abstract: Following models of vertically differentiated duopoly this paper deals with the influence of a social health system on the sustainability of the duopoly and on the respective prices. Emphasis is laid on the effect of a reduction of the coinsurance rate for drugs on prices and on the market structure. The results depend on the size of the relative effect such a reduction has on the rate of the disposable income. The social health system is assumed to be financed by deductions from the income of the insured. Conclusions are drawn with respect to different health systems.

Date: 1990
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/68865/1/686907493.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:kondp1:250

Access Statistics for this paper

More papers in Discussion Papers, Series I from University of Konstanz, Department of Economics Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics (econstor@zbw-workspace.eu).